BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dagan Lonsdale//NONSGML Clinical pharmacology year 2 Pharmacokinetics 2 (PHA503) calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:21ed0366-b541-422c-ab30-bcd907087b0d
DTSTAMP:20250908T125826Z
DTSTART:20251002T140000Z
DTEND:20251002T150000Z
SUMMARY:PK 3.1 Introduction to the pharmacokinetics module in year 2 and pharmacokinetic Parameter Estimations preparation
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:62e66e2a-5971-449f-9658-5992cccf724a
DTSTAMP:20250908T125826Z
DTSTART:20251007T090000Z
DTEND:20251007T100000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:2dcabd9e-81c7-46ec-8b34-a4dcc8092ebb
DTSTAMP:20250908T125826Z
DTSTART:20251007T100000Z
DTEND:20251007T110000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:bbfdc203-d2fd-4a39-bae6-a421d9c731e4
DTSTAMP:20250908T125826Z
DTSTART:20251007T110000Z
DTEND:20251007T120000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:2ec19e22-734c-4882-9209-bf5ab94a7d6c
DTSTAMP:20250908T125826Z
DTSTART:20251017T140000Z
DTEND:20251017T150000Z
SUMMARY:PK 3.3 Pre-clinical PK and animal to human predictions
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:b24dc700-a199-4fd9-8b1a-cca6881cca36
DTSTAMP:20250908T125826Z
DTSTART:20251021T090000Z
DTEND:20251021T100000Z
SUMMARY:PK 3.4  Blood Brain Barrier
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:5375d5da-c21e-45da-a437-dfb80df53b7f
DTSTAMP:20250908T125826Z
DTSTART:20251027T100000Z
DTEND:20251027T110000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:8c8efd51-277c-415f-829c-9bea5333a4e8
DTSTAMP:20250908T125826Z
DTSTART:20251027T110000Z
DTEND:20251027T120000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:345bc2f1-a2ba-4cdf-93b7-79a11ce0b260
DTSTAMP:20250908T125826Z
DTSTART:20251027T120000Z
DTEND:20251027T130000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:8b64dfc1-5f9d-4b8f-ad46-8740792c9515
DTSTAMP:20250908T125826Z
DTSTART:20251030T120000Z
DTEND:20251030T130000Z
SUMMARY:PK 3.6 Introduction to topics for Thursday PM  Joint Drug devt and PK
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:667afaa5-b3c5-46e4-8ec0-5899f5d236b1
DTSTAMP:20250908T125826Z
DTSTART:20251030T140000Z
DTEND:20251030T150000Z
SUMMARY:PK 3.7 study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq/Toqa, external lecturer David Carlisle
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:8f46bfee-91ab-4026-870f-417a573fe0b7
DTSTAMP:20250908T125826Z
DTSTART:20251030T150000Z
DTEND:20251030T160000Z
SUMMARY:PK 3.7 study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq/Toqa, external lecturer David Carlisle
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:423daef7-7c32-48cb-b21f-11ac472f4e85
DTSTAMP:20250908T125826Z
DTSTART:20251113T100000Z
DTEND:20251113T110000Z
SUMMARY:PK and drug development assignment drop in session
DESCRIPTION:Module - PHA503, Person delivering - Dagan, Ateeq
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:de080346-313f-4bac-8b5a-c766a85b170f
DTSTAMP:20250908T125826Z
DTSTART:20251113T110000Z
DTEND:20251113T120000Z
SUMMARY:PK 3.8 Pharmacogenomics
DESCRIPTION:Module - PHA503, Person delivering - Reya
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:ba2cea26-1a3b-4a51-8f02-0e8f8e2f7f5e
DTSTAMP:20250908T125826Z
DTSTART:20251113T120000Z
DTEND:20251113T130000Z
SUMMARY:PK 3.9 Bioequivalence 2
DESCRIPTION:Module - PHA503, Person delivering - Toqa
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:4dd0a163-b32c-4ad8-aa37-e14778ab593c
DTSTAMP:20250908T125826Z
DTSTART:20251205T140000Z
DTEND:20251205T150000Z
SUMMARY:PK 3.10 Pharmacokinetics and PD in aging and pregnancy
DESCRIPTION:Module - PHA503, Person delivering - ?Cleodie
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:18809291-6caf-42c8-bc67-d09c11e1f341
DTSTAMP:20250908T125826Z
DTSTART:20251208T100000Z
DTEND:20251208T110000Z
SUMMARY:PK 3.11 Pharmacokinetic Variability and Assignment Debrief
DESCRIPTION:Module - PHA503, Person delivering - Dagan, Toqa, Ateeq, Dan
LOCATION:Lecture theatre A
END:VEVENT
BEGIN:VEVENT
UID:de77d9bd-10b4-4d28-a429-16f265f7a036
DTSTAMP:20250908T125826Z
DTSTART:20260108T140000Z
DTEND:20260108T150000Z
SUMMARY:PK 3.12  Introduction to PK modelling
DESCRIPTION:Module - PHA503, Person delivering - Prof. Joe Standing
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:78b998d7-62df-48a6-9a21-67760de26707
DTSTAMP:20250908T125826Z
DTSTART:20260108T150000Z
DTEND:20260108T160000Z
SUMMARY:PK 3.13  Introduction to Compartmental analysis
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:
END:VEVENT
END:VCALENDAR
